Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02254278 · OUTCOME

Gross Tumor Volume (GTV) [for Purpose of Correlation]

Reduced-Dose Intensity-Modulated Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Oropharyngeal Cancer · Source last updated 2026-05-22

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
mL
Interval / dispersion
Full Range
Time frame
Baseline

What was measured

GTV is the volume of the tumor determined by imaging used for radiation treatment planning. The study protocol indicates that participants are analyzed as a single group, treatment arms combined. Correlation of Baseline Log HPV DNA Copy Number and Gross Tumor Volume (GTV) are reported in another outcome measure.

Analysis population: Eligible participants with baseline HPV DNA value

Groups in this outcome

Both Arms Combined

IMRT 6 Weeks + Cisplatin arm: Cisplatin: 40 mg/m2 IV (intravenously) weekly for 6 weeks; Intensity-modulated radiation therapy (IMRT), 30 fractions over 6 weeks, 5 fractions per week, 2 Gray per fraction to total dose of 60 Gy. IMRT 5 weeks arm: Intensity-modulated radiation therapy (IMRT), 30 fractions over 5 weeks, 6 fractions per week, 2 Gray per fraction to total dose of 60 Gy

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Both Arms Combined164

Reported measurements

Source class 1
Values in mL · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
Both Arms Combined25.7Not reported2.9131.7Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        2.9
        upper Limit
        131.7
        value
        25.7
denoms
  1. counts
    1. group Id
      OG000
      value
      164
    units
    Participants
description
GTV is the volume of the tumor determined by imaging used for radiation treatment planning. The study protocol indicates that participants are analyzed as a single group, treatment arms combined. Correlation of Baseline Log HPV DNA Copy Number and Gross Tumor Volume (GTV) are reported in another outcome measure.
dispersion Type
Full Range
groups
  1. description
    IMRT 6 Weeks + Cisplatin arm: Cisplatin: 40 mg/m2 IV (intravenously) weekly for 6 weeks; Intensity-modulated radiation therapy (IMRT), 30 fractions over 6 weeks, 5 fractions per week, 2 Gray per fraction to total dose of 60 Gy. IMRT 5 weeks arm: Intensity-modulated radiation therapy (IMRT), 30 fractions over 5 weeks, 6 fractions per week, 2 Gray per fraction to total dose of 60 Gy
    id
    OG000
    title
    Both Arms Combined
param Type
MEDIAN
population Description
Eligible participants with baseline HPV DNA value
reporting Status
POSTED
time Frame
Baseline
title
Gross Tumor Volume (GTV) [for Purpose of Correlation]
type
SECONDARY
unit Of Measure
mL

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice